Inflammation and Atrial Fibrillation

被引:0
作者
Endoh, Yasumi [1 ]
Endoh, Ikuko [1 ]
Geczy, Carolyn [2 ]
Nakagomi, Akihiro [1 ]
Kusama, Yoshiki [1 ]
Atarashi, Hirotsugu [1 ]
机构
[1] Tama Nagayama Hosp, Nippon Med Sch, Dept Internal Med, Div Cardiol, 1-7-1 Nagayama, Tama, Tokyo, Japan
[2] Univ New South Wales, Sch Med Sci, Inflammatory Dis Res Unit, Sydney, NSW, Australia
关键词
Atrial fibrillation; Inflammation; Resolution of inflammation;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Atrial fibrillation (AF) is the most common sustained arrhythmia encountered in clinical practice. Accumulating evidence indicates a link between inflammation and AF, and important advances in understanding mechanisms of AF are arising from studies of the critical components involved in the modulation of the immunoinflammatory balance within the atrium. However, molecular mechanisms remain unclear. Indeed, although preclinical and clinical studies suggest that chronic inflammation may promote development of AF, the roles of inflammation in the process are complex and incompletely understood. The purpose of this review is to briefly highlight current evidence on relationships between inflammation and AF, and to discuss possible mechanisms of development of AF and/or possible therapeutic approaches targeting components of the inflammatory response.
引用
收藏
页码:106 / 115
页数:10
相关论文
共 122 条
  • [1] Aikawa M, 2001, CIRCULATION, V103, P276
  • [2] Acute onset human atrial fibrillation is associated with local cardiac platelet activation and endothelial dysfunction
    Akar, Joseph G.
    Jeske, Walter
    Wilber, David J.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (18) : 1790 - 1793
  • [3] Effect of statin therapy on C-reactive protein levels - The Pravastatin Inflammation/CRP Evaluation (PRINCE): A randomized trial and cohort study
    Albert, MA
    Danielson, E
    Rifai, N
    Ridker, PM
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (01): : 64 - 70
  • [4] [Anonymous], 2001, CIRCULATION, V104, P2118
  • [5] Armesilla AL, 1999, MOL CELL BIOL, V19, P2032
  • [6] Familial aggregation of atrial fibrillation in Iceland
    Arnar, DO
    Thorvaldsson, S
    Manolio, TA
    Thorgeirsson, G
    Kristjansson, K
    Hakonarson, H
    Stefansson, K
    [J]. EUROPEAN HEART JOURNAL, 2006, 27 (06) : 708 - 712
  • [7] PROTHROMBIN FRAGMENT F1+2 AND THROMBIN ANTITHROMBIN-III COMPLEX ARE USEFUL MARKERS OF THE HYPERCOAGULABLE STATE IN ATRIAL-FIBRILLATION
    ASAKURA, H
    HIFUMI, S
    JOKAJI, H
    SAITO, M
    KUMABASHIRI, I
    UOTANI, C
    MORISHITA, E
    YAMAZAKI, M
    SHIBATA, K
    MIZUHASHI, K
    MIFUNE, J
    MATSUDA, T
    [J]. BLOOD COAGULATION & FIBRINOLYSIS, 1992, 3 (04) : 469 - 473
  • [8] Inflammation as a risk factor for atrial fibrillation
    Aviles, RJ
    Martin, DO
    Apperson-Hansen, C
    Houghtaling, PL
    Rautaharju, P
    Kronmal, RA
    Tracy, RP
    Van Wagoner, DR
    Psaty, BM
    Lauer, MS
    Chung, MK
    [J]. CIRCULATION, 2003, 108 (24) : 3006 - 3010
  • [9] New drugs for asthma
    Barnes, PJ
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2004, 3 (10) : 831 - 844
  • [10] Thrombogenesis in atrial fibrillation contributing mechanisms and natural history
    Becker, Richard C.
    [J]. JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2009, 27 (01) : 119 - 121